![]() |
市場調査レポート
商品コード
1331409
植物性賦形剤市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年Plant Based Excipients Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Type, By Application, By Region and Competition |
||||||
カスタマイズ可能
|
植物性賦形剤市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年 |
出版日: 2023年08月01日
発行: TechSci Research
ページ情報: 英文 113 Pages
納期: 2~3営業日
|
世界の植物性賦形剤市場は、医薬品を含む様々な産業における天然で持続可能な製品に対する需要の高まりにより、予測期間中に目覚ましい成長が見込まれています。
植物別の賦形剤は、石油のような再生不可能な資源に由来することが多い従来の賦形剤に代わる、より持続可能で環境に優しい代替品として注目されています。消費者は製品が環境に与える影響をますます気にするようになり、より持続可能な代替品を求めるようになっています。世界中の消費者と政府が持続可能性に重点を置くようになったことで、今後数年間、世界の植物性賦形剤市場の成長に新たな展望が生まれると期待されています。
近年、医薬品製剤における植物性賦形剤の使用に注目が集まっています。その背景には、医薬品における天然で持続可能かつ安全な成分への需要の高まりがあります。植物性賦形剤は、従来の賦形剤と比較して、溶解性の向上、バイオアベイラビリティの改善、毒性の低減など、いくつかの利点があります。植物性賦形剤の成長を支援するために、いくつかの有利な規制が設けられています。これらの規制は、医薬品における天然成分や持続可能な成分の使用を奨励し、革新的な植物性賦形剤の開発を促進するものです。FDAのGRAS(Generally Recognized as Safe)リストは、食品や医薬品への使用が安全とされる物質のリストです。このリストには、セルロース、デンプン、ペクチンなど、いくつかの植物性賦形剤が含まれています。これらの賦形剤がGRASリストに掲載されたことで、安全であるとみなされ、大規模な安全性試験を必要としないため、医薬品製剤での使用が促進されました。これにより、世界の植物性賦形剤市場の成長に有利な機会が生まれると期待されています。さらに、欧州薬局方は欧州における医薬品の規格とガイドラインのセットです。この薬局方には、微結晶セルロース、デンプン、乳糖などの植物性賦形剤に関するモノグラフがいくつか含まれています。これらのモノグラフは、これらの賦形剤の品質や仕様に関する詳細な情報を提供し、医薬品製剤への使用を奨励しています。また、国際医薬品添加剤評議会(IPEC)は、植物性賦形剤を含む医薬品添加剤の品質と安全性に関するガイドラインを提供しています。これらのガイドラインは、植物性賦形剤が医薬品に使用するために必要な品質基準を満たしていることを保証するものです。このような支援的な規制環境は、今後数年間、世界の植物性賦形剤市場の成長を促進すると予想されます。
長年にわたり、植物性賦形剤に関連する調査は、その費用対効果と患者の健康に対する副作用の少なさを理由に大幅に増加しています。植物性賦形剤は、製薬業界において従来の賦形剤に代わる、より持続可能で環境に優しい代替品として、近年注目を集めています。その結果、植物性賦形剤の特性や用途に関する研究が盛んに行われるようになり、世界の植物性賦形剤市場の成長に新たな展望が生まれています。例えば、アルギン酸は褐藻由来の多糖類であり、医薬品の賦形剤として使用されてきました。最近の研究では、難水溶性薬物の溶解性とバイオアベイラビリティを改善するために使用できるアルギン酸別の賦形剤の開発に焦点が当てられています。アルギン酸別の賦形剤には粘着性があることも分かっており、体内の特定の部位をターゲットとするドラッグデリバリーシステムでの使用に適しています。同様に、セルロースも植物に含まれる天然ポリマーであり、医薬品の賦形剤として使用されてきました。最近の研究では、薬剤の安定性と溶解性を改善するために使用できるセルロース系賦形剤の開発に焦点が当てられています。また、セルロース系賦形剤には抗酸化作用があることが判明しており、酸化ストレス関連疾患をターゲットとする医薬品の開発に適しています。
結論として、最近の研究では、薬物の溶解性、安定性、バイオアベイラビリティを改善するために使用できる植物性賦形剤の開発に焦点が当てられています。アルギン酸、セルロース、デンプン、タンパク質、ガムなどの植物性賦形剤は、製薬業界における様々な用途で有望視されています。この分野の研究が進むにつれて、より多くの植物性賦形剤が開発され、新薬の市場開拓に使用されることが予想され、世界の植物性賦形剤市場の成長を支えています。
TechSci Researchでは、所定の市場データを使用して、企業固有のニーズに応じたカスタマイズを提供しています。レポートでは以下のカスタマイズが可能です:
Global Plant Based Excipients Market is expected to grow at an impressive rate during the forecast period on account of the growing demand for natural and sustainable products in various industries, including pharmaceuticals. Plant-based excipients are seen as a more sustainable and eco-friendlier alternative to traditional excipients, which are often derived from non-renewable sources such as petroleum. Consumers are increasingly concerned about the environmental impact of products and are seeking more sustainable alternatives. The shifting focus of consumers and governments across the globe towards sustainability is expected to create new prospects for the growth of global plant based excipients market in the coming years.
Plant based excipients are derived from natural sources such as algae, starches, cellulose, gums, and proteins and are used to improve the stability, solubility, and bioavailability of drugs. Plant based excipients are considered safer than traditional excipients because they are derived from natural sources and are less likely to cause adverse reactions in patients. In addition, plant based excipients are free from potential contaminants and impurities that may be present in synthetic excipients. This, in turn, is expected to drive the growth of global plant based excipients market during the forecast period.
There has been a growing trend towards using plant based excipients in combination with other natural ingredients. For example, Hydroxy Propyl Methyl Cellulose (HPMC), a widely used plant based excipient, has been combined with natural gums such as guar gum, xanthan gum, and locust bean gum to improve tablet hardness and disintegration. This approach has resulted in a more natural and sustainable product while maintaining the required quality and efficacy of the drug. This, in turn, is expected to spur the demand for plant based excipients thereby driving the growth of global plant based excipients market in the next few years.
In recent years, there has been an increasing focus on the use of plant-based excipients in pharmaceutical formulations. This is due to the growing demand for natural, sustainable, and safe ingredients in pharmaceutical products. Plant-based excipients offer several benefits over traditional excipients, including better solubility, improved bioavailability, and reduced toxicity. To support the growth of plant-based excipients, there have been several favorable regulations put in place. These regulations encourage the use of natural and sustainable ingredients in pharmaceuticals and promote the development of innovative plant-based excipients. The FDA's GRAS (Generally Recognized as Safe) list is a list of substances that are considered safe for use in food and pharmaceutical products. The list includes several plant-based excipients such as cellulose, starch, and pectin. The inclusion of these excipients on the GRAS list has encouraged their use in pharmaceutical formulations, as they are considered safe and do not require extensive safety testing. This, in turn, is expected to create lucrative opportunities for the growth of global plant-based excipients market. Additionally, The European Pharmacopoeia is a set of standards and guidelines for pharmaceutical products in Europe. The pharmacopeia includes several monographs on plant-based excipients, such as microcrystalline cellulose, starch, and lactose. These monographs provide detailed information on the quality and specifications of these excipients, which has encouraged their use in pharmaceutical formulations. Also, the International Pharmaceutical Excipients Council (IPEC) provides guidelines on the quality and safety of pharmaceutical excipients, including plant-based excipients. These guidelines ensure that plant-based excipients meet the necessary quality standards for use in pharmaceutical products. Such a supportive regulatory environment is expected to foster the growth of global plant-based excipients market in the coming years.
Over the years, research related to plant based excipients has significantly increased on account of their cost-effectiveness and lesser adverse reactions to patient health. Plant based excipients have gained a lot of attention in recent years as a more sustainable and eco-friendlier alternative to traditional excipients in the pharmaceutical industry. As a result, there has been a significant amount of research conducted on the properties and applications of plant-based excipients, thereby creating new prospects for the growth of global plant based excipients market. For instance, alginate is a polysaccharide that is derived from brown seaweed and has been used as an excipient in pharmaceuticals. Recent research has focused on the development of alginate-based excipients that can be used to improve the solubility and bioavailability of poorly water-soluble drugs. Alginate-based excipients have also been found to have mucoadhesive properties, making them suitable for use in drug-delivery systems that target specific sites in the body. Similarly, cellulose is a natural polymer that is found in plants and has been used as an excipient in pharmaceuticals. Recent research has focused on the development of cellulose-based excipients that can be used to improve the stability and solubility of drugs. Cellulose-based excipients have also been found to have antioxidant properties, making them suitable for use in the development of drugs that target oxidative stress-related diseases.
In conclusion, recent research has focused on the development of plant-based excipients that can be used to improve the solubility, stability, and bioavailability of drugs. Plant-based excipients such as alginate, cellulose, starch, proteins, and gums have shown promise in various applications in the pharmaceutical industry. As research in this field continues to advance, it can be expected that more plant based excipients will be developed and used in the development of new drugs, thereby supporting the growth of global plant based excipients market.
Global Plant Based Excipients Market can be segmented by type, application, and by region. Based on type, the Global Plant Based Excipients market can be categorized into carbohydrates, proteins, polymers, minerals, glycoside & waxes, esters, and others. By application, the Global Plant Based Excipients market can be fragmented into binders & diluents, glidants, lubricants & disintegrants, film forming & coating agents, plasticizers, suspending agents, and others. Regionally, the Global Plant Based Excipients market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. Among different countries, United States is expected to dominate the global plant based excipients market. In the United States, there has been a growing interest in plant based excipients due to the increasing demand for natural and sustainable ingredients. The FDA has recognized many plant-based excipients as Generally Recognized as Safe (GRAS) for use in pharmaceuticals. The use of plant-based excipients in cosmetics is also gaining popularity due to the trend toward natural and organic products. This, in turn, will support the growth of plant based excipients market.
Roquette Freres SA, EVONIK Industries, Inc., DFE Pharma GmbH & Co.KG, Lonza Group, BASF SE, Novartis International AG, FMC Corporation, JRS Pharma LP, among others, are some of the leading players operating in the Global Plant Based Excipients market.
In this report, Global Plant Based Excipients Market has been segmented into following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Global Plant Based Excipients Market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: